Skip to main content
Top
Published in: Digestive Diseases and Sciences 1/2009

01-01-2009 | Original Article

Impairment by 5-Fluorouracil of the Healing of Gastric Lesions in Rats: Effect of Lafutidine, a Histamine H2 Receptor Antagonist, Mediated by Capsaicin-Sensitive Afferent Neurons

Authors: Yukiko Murashima, Tohru Kotani, Shusaku Hayashi, Yoshino Komatsu, Akari Nakagiri, Kikuko Amagase, Koji Takeuchi

Published in: Digestive Diseases and Sciences | Issue 1/2009

Login to get access

Abstract

We investigated the influence of 5-fluorouracil (5-FU), an anti-tumor agent, on the healing of gastric lesions generated by 0.6 M HCl in rats and the effect of lafutidine, a histamine H2 receptor antagonist, on the impaired healing. Animals fasted for 18 h were given 1 ml of 0.6 M HCl p.o., fed normally from 1 h later, and killed 1–96 h thereafter. 5-FU was given i.v. twice, 1 h and 24 h after the HCl. The gastric lesions healed spontaneously within 96 h. Although it decreased acid secretion, 5-FU markedly delayed the healing. Lafutidine, but not cimetidine, given p.o. immediately after each dosing of 5-FU significantly reversed the delay in healing by 5-FU, and this effect was attenuated by the chemical ablation of capsaicin-sensitive afferent neurons. Capsaicin also significantly reversed the delay in healing. The mucosal application of 50 mM HCl did not affect gastric mucosal blood flow (GMBF) in the normal stomach, but significantly increased it in the stomach damaged by 0.6 M HCl. The increases in GMBF were attenuated by 5-FU; however, the co-administration of lafutidine significantly restored the response. In addition, 5-FU inhibited both cell proliferation and migration in rat gastric epithelial cells (RGM1) in vitro. These results suggest that 5-FU delayed the healing of gastric lesions generated by 0.6 M HCl, probably through the inhibition of cell migration and proliferation, as well as the impairment of GMBF, and lafutidine reversed the delay in healing, mainly through the amelioration of the GMBF response mediated by capsaicin-sensitive afferent neurons.
Literature
2.
go back to reference Nomoto K, Yokokura T, Nomoto K (1992) Prevention of 5-fluorouracil-induced infection with indigenous Escherichia coli in tumor-bearing mice by nonspecific immunostimulation. Can J Microbiol 38:774–778PubMedCrossRef Nomoto K, Yokokura T, Nomoto K (1992) Prevention of 5-fluorouracil-induced infection with indigenous Escherichia coli in tumor-bearing mice by nonspecific immunostimulation. Can J Microbiol 38:774–778PubMedCrossRef
4.
go back to reference Hirata K, Horie T (1999) A prostaglandin E1 analog, OP-1206, alleviates 5-fluorouracil-induced injury of rat small intestine. Res Commun Mol Pathol Pharmacol 104:243–251PubMed Hirata K, Horie T (1999) A prostaglandin E1 analog, OP-1206, alleviates 5-fluorouracil-induced injury of rat small intestine. Res Commun Mol Pathol Pharmacol 104:243–251PubMed
5.
go back to reference Siber GR, Mayer RJ, Levin MJ (1980) Increased gastrointestinal absorption of large molecules in patients after 5-fluorouracil therapy for metastatic colon carcinoma. Cancer Res 40:3430–3436PubMed Siber GR, Mayer RJ, Levin MJ (1980) Increased gastrointestinal absorption of large molecules in patients after 5-fluorouracil therapy for metastatic colon carcinoma. Cancer Res 40:3430–3436PubMed
6.
go back to reference Polloni A, Marchi S, Costa F, Cecconi N, Ruocco L, Maltinti G, Grassi B, Del Tacca M (1986) Pirenzepine versus ranitidine in gastroprotection during antiblastic chemotherapy: a double-blind study. Chemotherapia 6:420–423 Polloni A, Marchi S, Costa F, Cecconi N, Ruocco L, Maltinti G, Grassi B, Del Tacca M (1986) Pirenzepine versus ranitidine in gastroprotection during antiblastic chemotherapy: a double-blind study. Chemotherapia 6:420–423
7.
go back to reference Sartori S, Nielsen I, Maestri A, Beltrami D, Trevisani L, Pazzi P (1991) Acute gastroduodenal mucosal injury after cisplatin plus etoposide chemotherapy. Clinical and endoscopic study. Oncology 48:356–361PubMed Sartori S, Nielsen I, Maestri A, Beltrami D, Trevisani L, Pazzi P (1991) Acute gastroduodenal mucosal injury after cisplatin plus etoposide chemotherapy. Clinical and endoscopic study. Oncology 48:356–361PubMed
8.
go back to reference Kakinuma S, Ohwada S (1997) Gastric mucosal blood flow and gastric secretion following intravenous administration of 5-fluorouracil in anesthetized rats. Cancer Chemother Pharmacol 39:357–360. doi:10.1007/s002800050583 PubMedCrossRef Kakinuma S, Ohwada S (1997) Gastric mucosal blood flow and gastric secretion following intravenous administration of 5-fluorouracil in anesthetized rats. Cancer Chemother Pharmacol 39:357–360. doi:10.​1007/​s002800050583 PubMedCrossRef
10.
go back to reference Sartori S, Trevisani L, Nielsen I, Tassinari D, Panzini I, Abbasciano V (2000) Randomized trial of omeprazole or ranitidine versus placebo in the prevention of chemotherapy-induced gastroduodenal injury. J Clin Oncol 18:463–467PubMed Sartori S, Trevisani L, Nielsen I, Tassinari D, Panzini I, Abbasciano V (2000) Randomized trial of omeprazole or ranitidine versus placebo in the prevention of chemotherapy-induced gastroduodenal injury. J Clin Oncol 18:463–467PubMed
11.
go back to reference Shibata M, Yamaura T, Inaba N, Onodera S, Chida Y, Ohnishi H (1993) Gastric antisecretory effect of FRG-8813, a new histamine H2 receptor antagonist, in rats and dogs. Eur J Parmacol 235:245–253. doi:10.1016/0014-2999(93)90143-6 CrossRef Shibata M, Yamaura T, Inaba N, Onodera S, Chida Y, Ohnishi H (1993) Gastric antisecretory effect of FRG-8813, a new histamine H2 receptor antagonist, in rats and dogs. Eur J Parmacol 235:245–253. doi:10.​1016/​0014-2999(93)90143-6 CrossRef
12.
13.
go back to reference Kato S, Tanaka A, Kunikata T, Umeda M, Takeuchi K (2000) Protective effect of lafutidine against indomethacin-induced intestinal ulceration in rats: relation to capsaicin-sensitive sensory neurons. Digestion 61:39–46. doi:10.1159/000007734 PubMedCrossRef Kato S, Tanaka A, Kunikata T, Umeda M, Takeuchi K (2000) Protective effect of lafutidine against indomethacin-induced intestinal ulceration in rats: relation to capsaicin-sensitive sensory neurons. Digestion 61:39–46. doi:10.​1159/​000007734 PubMedCrossRef
14.
go back to reference Onodera S, Nishida K, Takeuchi K (2004) Unique profile of lafutidine, a novel histamine H2-receptor antagonist: mucosal protection throughout gastrointestinal tract mediated by capsaicin-sensitive afferent neurons. Curr Pharm Design 1:133–144 Onodera S, Nishida K, Takeuchi K (2004) Unique profile of lafutidine, a novel histamine H2-receptor antagonist: mucosal protection throughout gastrointestinal tract mediated by capsaicin-sensitive afferent neurons. Curr Pharm Design 1:133–144
15.
go back to reference Fukushima K, Aoi Y, Kato S, Takeuchi K (2006) Gastro-protective action of lafutidine mediated by capsaicin-sensitive afferent neurons without interaction with TRPV1 and involvement of endogenous prostaglandins. World J Gastroenterol 12:3031–3037PubMed Fukushima K, Aoi Y, Kato S, Takeuchi K (2006) Gastro-protective action of lafutidine mediated by capsaicin-sensitive afferent neurons without interaction with TRPV1 and involvement of endogenous prostaglandins. World J Gastroenterol 12:3031–3037PubMed
16.
go back to reference Kotani T, Nakagiri A, Murashima Y, Takeuchi K (2007) Prophylactic effect of lafutidine against the adverse reaction induced in rat stomach by repeated administration of 5-fluorouracil. Inflammopharmacology 15:203–208. doi:10.1007/s10787-007-1593-1 PubMedCrossRef Kotani T, Nakagiri A, Murashima Y, Takeuchi K (2007) Prophylactic effect of lafutidine against the adverse reaction induced in rat stomach by repeated administration of 5-fluorouracil. Inflammopharmacology 15:203–208. doi:10.​1007/​s10787-007-1593-1 PubMedCrossRef
17.
go back to reference Kobayashi I, Kawano S, Tsuji S, Matsui H, Nakama A, Sawaoka H, Masuda E, Takei Y, Nagano K, Fusamoto H, Ohno T, Fukutomi H, Kamada T (1996) RGM1, a cell line derived from normal gastric mucosa of rat. In Vitro Cell Dev Biol Anim 32:259–261. doi:10.1007/BF02723056 PubMedCrossRef Kobayashi I, Kawano S, Tsuji S, Matsui H, Nakama A, Sawaoka H, Masuda E, Takei Y, Nagano K, Fusamoto H, Ohno T, Fukutomi H, Kamada T (1996) RGM1, a cell line derived from normal gastric mucosa of rat. In Vitro Cell Dev Biol Anim 32:259–261. doi:10.​1007/​BF02723056 PubMedCrossRef
19.
go back to reference Holzer P, Sametz W (1986) Gastric mucosal protection against ulcerogenic factors in the rat mediated by capsaicin-sensitive afferent neurons. Gastroenterology 91:975–981PubMed Holzer P, Sametz W (1986) Gastric mucosal protection against ulcerogenic factors in the rat mediated by capsaicin-sensitive afferent neurons. Gastroenterology 91:975–981PubMed
20.
go back to reference Takeuchi K, Ueshima K, Ohuchi T, Okabe S (1994) The role of capsaicin-sensitive sensory neurons in healing of HCl-induced gastric mucosal lesions in rats. Gastroenterology 106:1524–1532PubMed Takeuchi K, Ueshima K, Ohuchi T, Okabe S (1994) The role of capsaicin-sensitive sensory neurons in healing of HCl-induced gastric mucosal lesions in rats. Gastroenterology 106:1524–1532PubMed
22.
go back to reference Chen D, Wu G, Wang W, Wang J (1997) Neutrophil infiltration is involved in 5-fluorouracil induced lipid peroxidative damage of the small intestine. Chin Med Sci J 12:181–183PubMed Chen D, Wu G, Wang W, Wang J (1997) Neutrophil infiltration is involved in 5-fluorouracil induced lipid peroxidative damage of the small intestine. Chin Med Sci J 12:181–183PubMed
23.
go back to reference Gómez de Segura IA, Valderrábano S, Vázquez I, Vallego-Cremades MT, Gómez-García L, Sánchez M, de Miguel E (2004) Protective effects of dietary enrichment with docosahexaenoic acid plus protein in 5-fluorouracil-induced intestinal injury in the rat. Eur J Gastroenterol Hepatol 16:479–485. doi:10.1097/00042737-200405000-00008 PubMedCrossRef Gómez de Segura IA, Valderrábano S, Vázquez I, Vallego-Cremades MT, Gómez-García L, Sánchez M, de Miguel E (2004) Protective effects of dietary enrichment with docosahexaenoic acid plus protein in 5-fluorouracil-induced intestinal injury in the rat. Eur J Gastroenterol Hepatol 16:479–485. doi:10.​1097/​00042737-200405000-00008 PubMedCrossRef
24.
go back to reference Holzer P, Livingston EH, Saria A, Guth PH (1991) Sensory neurons mediate protective vasodilatation in rat gastric mucosa. Am J Physiol 260:G363–G370PubMed Holzer P, Livingston EH, Saria A, Guth PH (1991) Sensory neurons mediate protective vasodilatation in rat gastric mucosa. Am J Physiol 260:G363–G370PubMed
25.
go back to reference Takeuchi K, Kato S, Takehara K, Asada Y, Yasuhiro T (1997) Role of nitric oxide in mucosal blood flow response and the healing of HCl-induced lesions in the rat stomach. Digestion 58:19–27PubMedCrossRef Takeuchi K, Kato S, Takehara K, Asada Y, Yasuhiro T (1997) Role of nitric oxide in mucosal blood flow response and the healing of HCl-induced lesions in the rat stomach. Digestion 58:19–27PubMedCrossRef
26.
go back to reference Basaki Y, Chikahisa L, Aoyagi K, Miyadera K, Yonekura K, Hashimoto A, Okabe S, Wierzba K, Yamada Y (2001) γ-Hydroxybutyric acid and 5-fluorouracil, metabolites of UFT, inhibit the angiogenesis induced by vascular endothelial growth factor. Angiogenesis 4:163–173. doi:10.1023/A:1014059528046 PubMedCrossRef Basaki Y, Chikahisa L, Aoyagi K, Miyadera K, Yonekura K, Hashimoto A, Okabe S, Wierzba K, Yamada Y (2001) γ-Hydroxybutyric acid and 5-fluorouracil, metabolites of UFT, inhibit the angiogenesis induced by vascular endothelial growth factor. Angiogenesis 4:163–173. doi:10.​1023/​A:​1014059528046 PubMedCrossRef
27.
go back to reference Tarnawski A (1993) Cellular mechanisms of gastric ulcer healing. In: Domschke W, Konturek SJ (eds) The stomach. Springer, Berlin, New York, pp 177–192 Tarnawski A (1993) Cellular mechanisms of gastric ulcer healing. In: Domschke W, Konturek SJ (eds) The stomach. Springer, Berlin, New York, pp 177–192
28.
go back to reference Tramontana M, Renzi D, Calabrò A, Panerai C, Milani S, Surrenti C, Evangelista S (1994) Influence of capsaicin-sensitive afferent fibers on acetic acid-induced chronic gastric ulcers in rats. Scand J Gastroenterol 29:406–413. doi:10.3109/00365529409096830 PubMedCrossRef Tramontana M, Renzi D, Calabrò A, Panerai C, Milani S, Surrenti C, Evangelista S (1994) Influence of capsaicin-sensitive afferent fibers on acetic acid-induced chronic gastric ulcers in rats. Scand J Gastroenterol 29:406–413. doi:10.​3109/​0036552940909683​0 PubMedCrossRef
29.
go back to reference Ohno T, Hattori Y, Komine R, Ae T, Mizuguchi S, Arai K, Saeki T, Suzuki T, Hosono K, Hayashi I, Oh-Hashi Y, Kurihara Y, Kurihara H, Amagase K, Okabe S, Saigenji K, Majima M (2008) Roles of calcitonin gene-related peptide in maintenance of gastric mucosal integrity and in enhancement of ulcer healing and angiogenesis. Gastroenterology 134:215–225. doi:10.1053/j.gastro.2007.10.001 PubMedCrossRef Ohno T, Hattori Y, Komine R, Ae T, Mizuguchi S, Arai K, Saeki T, Suzuki T, Hosono K, Hayashi I, Oh-Hashi Y, Kurihara Y, Kurihara H, Amagase K, Okabe S, Saigenji K, Majima M (2008) Roles of calcitonin gene-related peptide in maintenance of gastric mucosal integrity and in enhancement of ulcer healing and angiogenesis. Gastroenterology 134:215–225. doi:10.​1053/​j.​gastro.​2007.​10.​001 PubMedCrossRef
30.
go back to reference Takeuchi K, Ohuchi T, Okabe S (1994) Endogenous nitric oxide in gastric alkaline response in the rat stomach after damage. Gastroenterology 106:367–374PubMed Takeuchi K, Ohuchi T, Okabe S (1994) Endogenous nitric oxide in gastric alkaline response in the rat stomach after damage. Gastroenterology 106:367–374PubMed
32.
go back to reference Davenport HW, Warner HA, Code CF (1964) Functional significance of gastric mucosal barrier to sodium. Gastroenterology 47:142–152PubMed Davenport HW, Warner HA, Code CF (1964) Functional significance of gastric mucosal barrier to sodium. Gastroenterology 47:142–152PubMed
33.
go back to reference Li DS, Raybould HE, Quintero E, Guth PH (1992) Calcitonin gene-related peptide mediates the gastric hyperemic response to acid back-diffusion. Gastroenterology 102:1124–1128PubMed Li DS, Raybould HE, Quintero E, Guth PH (1992) Calcitonin gene-related peptide mediates the gastric hyperemic response to acid back-diffusion. Gastroenterology 102:1124–1128PubMed
35.
go back to reference Mimaki H, Kagawa S, Aoi M, Kato S, Satoshi T, Kohama K, Takeuchi K (2002) Effect of lafutidine, a histamine H2-receptor antagonist, on gastric mucosal blood flow and duodenal HCO 3 − secretion in rats: relation to capsaicin-sensitive afferent neurons. Dig Dis Sci 47:2696–2703. doi:10.1023/A:1021021625569 PubMedCrossRef Mimaki H, Kagawa S, Aoi M, Kato S, Satoshi T, Kohama K, Takeuchi K (2002) Effect of lafutidine, a histamine H2-receptor antagonist, on gastric mucosal blood flow and duodenal HCO 3 secretion in rats: relation to capsaicin-sensitive afferent neurons. Dig Dis Sci 47:2696–2703. doi:10.​1023/​A:​1021021625569 PubMedCrossRef
Metadata
Title
Impairment by 5-Fluorouracil of the Healing of Gastric Lesions in Rats: Effect of Lafutidine, a Histamine H2 Receptor Antagonist, Mediated by Capsaicin-Sensitive Afferent Neurons
Authors
Yukiko Murashima
Tohru Kotani
Shusaku Hayashi
Yoshino Komatsu
Akari Nakagiri
Kikuko Amagase
Koji Takeuchi
Publication date
01-01-2009
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 1/2009
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-008-0325-8

Other articles of this Issue 1/2009

Digestive Diseases and Sciences 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine